Oncology Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2013	FY 2011	FY 2004	FY 2003	FY 2002	2001 - 1997
Period Ending	Mar '26 Mar 4, 2026	Mar '13 Mar 31, 2013	Jun '11 Jun 30, 2011	Mar '04 Mar 31, 2004	Mar '03 Mar 31, 2003	Mar '02 Mar 31, 2002	2001 - 1997
Last Close Price	0.01	1000000.00	10000000.00	12500000.00	52500000.00	325000000.00	Upgrade
Debt / Equity Ratio	-1.86	-1.86	-1.62	-0.14	-	-	Upgrade
Debt / FCF Ratio	555.27	555.27	-	-	-	-	Upgrade
Net Debt / Equity Ratio	-1.82	-1.82	-1.62	-0.10	-1.54	-1.24	Upgrade
Net Debt / EBITDA Ratio	-46.43	-46.43	-	-0.01	1.21	1.75	Upgrade
Net Debt / FCF Ratio	542.69	542.69	-	-0.01	0.85	1.66	Upgrade
Asset Turnover	-	-	-	1.31	1.22	0.84	Upgrade
Quick Ratio	0.04	0.04	-	0.12	1.73	2.42	Upgrade
Current Ratio	0.88	0.88	0.25	0.22	1.79	2.50	Upgrade
Return on Equity (ROE)	-	-	-	-447.14%	-93.71%	-64.37%	Upgrade
Return on Assets (ROA)	-	-	-	-118.19%	-35.06%	-28.79%	Upgrade
Return on Invested Capital (ROIC)	-6.83%	-6.83%	121.89%	-	-	-	Upgrade
Return on Capital Employed (ROCE)	100.70%	100.70%	-14.70%	989.00%	-172.50%	-85.00%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.